Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The report serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider transactions rather than a financial performance report.
Material Changes
The material change disclosed is a transfer of 1,128 Ordinary shares by Mrs. V A Whyte (a Person Discharging Managerial Responsibility) to her connected person, Mr. I Whyte, by way of gift on May 7, 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly details the share transaction in accordance with Disclosure Rule 3.1.4R(1)(a) and (c).
Investor Verification Checklist
- Verify the total shareholding of Mrs. V A Whyte and Mr. I Whyte following the gift of 1,128 shares.
- Confirm the date of notification to the Company and the SEC (May 7, 2013).
- Review the company's broader insider trading policies to ensure compliance with the disclosed transaction.